Listar Producción Científica por autor "Gil, Carmen"
Mostrando ítems 1-3 de 3
-
Article
Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical in silico/in vitro screening methods (2021)
Ginex, Tiziana; Garaigorta, Urtzi; Ramírez, David; Castro, Victoria; Nozal, Vanesa; Maestro, Inés; Garcıá-Cárceles, Javier; Campillo, N. E.; Martínez, Ana; Gastaminza, Pablo; ... (MDPI AG, 2021)The unprecedent situation generated by the COVID-19 global emergency has prompted us to actively work to fight against this pandemic by searching for repurposable agents among FDA approved drugs to shed light into immediate ... -
Article
Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19 (2024)
Alegría-Arcos, Melissa; Barbosa, Tábata; Sepúlveda, Felipe; Combariza, German; González, Janneth; Gil, Carmen; Martínez, Ana; Ramírez, David (Frontiers Media S.A., 2022)The coronavirus disease 2019 pandemic accelerated drug/vaccine development processes, integrating scientists all over the globe to create therapeutic alternatives against this virus. In this work, we have collected information ... -
Article
Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis (2020)
Rojas-Prats, Elisa; Martínez-González, Loreto; Gonzalo-Consuegra, Claudia; Liachko, Nicole F.; Pérez, Concepción; Ramírez, David; Kraemer, Brian C.; Martín-Requero, Ángeles; Perez, Daniel I.; Gil, Carmen; ... (Elsevier Masson s.r.l., 2020-10-28)Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no known cure. Aggregates of the nuclear protein TDP-43 have been recognized as a hallmark of proteinopathy in both familial and sporadic cases ...